Original Paper

Journal of Computer-Aided Molecular Design

, Volume 21, Issue 4, pp 145-153

First online:

3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach

  • Zhuoyong ZhangAffiliated withDepartment of Chemistry, Capital Normal University Email author 
  • , Liying AnAffiliated withDepartment of Chemistry, Capital Normal University
  • , Wenxiang HuAffiliated withDepartment of Chemistry, Capital Normal University
  • , Yuhong XiangAffiliated withDepartment of Chemistry, Capital Normal University

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The three-dimensional quantitative structure–activity relationship (3D-QSAR) has been studied on 90 hallucinogenic phenylalkylamines by the comparative molecular field analysis (CoMFA). Two conformations were compared during the modeling. Conformation I referred to the amino group close to ring position 6 and conformation II related to the amino group trans to the phenyl ring. Satisfactory results were obtained by using both conformations. There were still differences between the two models. The model based on conformation I got better statistical results than the one about conformation II. And this may suggest that conformation I be preponderant when the hallucinogenic phenylalkylamines interact with the receptor. To further confirm the predictive capability of the CoMFA model, 18 compounds with conformation I were randomly selected as a test set and the remaining ones as training set. The best CoMFA model based on the training set had a cross-validation coefficient q 2 of 0.549 at five components and non cross-validation coefficient R 2 of 0.835, the standard error of estimation was 0.219. The model showed good predictive ability in the external test with a coefficient R pre 2 of 0.611. The CoMFA coefficient contour maps suggested that both steric and electrostatic interactions play an important role. The contributions from the steric and electrostatic fields were 0.450 and 0.550, respectively.


3D-QSAR Amphetamines CoMFA Hallucinogen Phenylethylamines